These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15263791)

  • 1. E-cadherin expression in prostate adenocarcinomas in Chinese and its pathological correlates.
    Hsu YS; Wang JS; Wu TT
    Urol Int; 2004; 73(1):36-40. PubMed ID: 15263791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
    De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
    Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features.
    Köksal IT; Ozcan F; Kiliçaslan I; Tefekli A
    Pathology; 2002 Jun; 34(3):233-8. PubMed ID: 12109783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of p53, bcl-2 and E-cadherin expression in predicting biochemical relapse for organ confined prostate cancer in Taiwan.
    Wu TT; Hsu YS; Wang JS; Lee YH; Huang JK
    J Urol; 2003 Jul; 170(1):78-81. PubMed ID: 12796649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
    Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
    Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of E-cadherin and N-cadherin in prostate cancer and their implications].
    Liu Y; Chen XG; Liang CZ
    Zhonghua Nan Ke Xue; 2014 Sep; 20(9):781-6. PubMed ID: 25306803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
    Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of some tissue and serum biomarkers in prostatic carcinoma among Egyptian males.
    Ahmed MI; Abd-Elmotelib F; Farag RM; Ziada NA; Khalifa A
    Clin Biochem; 1999 Aug; 32(6):439-45. PubMed ID: 10667479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
    van Oort IM; Tomita K; van Bokhoven A; Bussemakers MJ; Kiemeney LA; Karthaus HF; Witjes JA; Schalken JA
    Prostate; 2007 Sep; 67(13):1432-8. PubMed ID: 17639504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
    Kuniyasu H; Troncoso P; Johnston D; Bucana CD; Tahara E; Fidler IJ; Pettaway CA
    Clin Cancer Res; 2000 Jun; 6(6):2295-308. PubMed ID: 10873080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-cadherin switching occurs in high Gleason grade prostate cancer.
    Jaggi M; Nazemi T; Abrahams NA; Baker JJ; Galich A; Smith LM; Balaji KC
    Prostate; 2006 Feb; 66(2):193-9. PubMed ID: 16173043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer.
    Drivalos A; Chrisofos M; Efstathiou E; Kapranou A; Kollaitis G; Koutlis G; Antoniou N; Karanastasis D; Dimopoulos MA; Bamias A
    Urol Oncol; 2016 Apr; 34(4):165.e11-8. PubMed ID: 26652134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
    Kuniyasu H; Ukai R; Johnston D; Troncoso P; Fidler IJ; Pettaway CA
    Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
    Kuczyk M; Serth J; Machtens S; Bokemeyer C; Bathke W; Stief C; Jonas U
    Br J Urol; 1998 Mar; 81(3):406-12. PubMed ID: 9523661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
    Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
    Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
    Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.